Regulation of the Human GLUT4 Gene Promoter: Interaction Between a Transcriptional Activator and Myocyte Enhancer Factor 2A
Overview
Affiliations
The GLUT4 gene is subject to complex tissue-specific and metabolic regulation, with a profound impact on insulin-mediated glucose disposal. We have shown, by using transgenic mice, that the human GLUT4 promoter is regulated through the cooperative function of two distinct regulatory elements, domain 1 and the myocyte enhancer factor 2 (MEF2) domain. The MEF2 domain binds transcription factors MEF2A and MEF2D in vivo. Domain I binds a transcription factor, GLUT4 enhancer factor (GEF). In this report, we show a restricted pattern of GEF expression in human tissues, which overlaps with MEF2A only in tissues expressing high levels of GLUT4, suggesting the hypothesis that GEF and MEF2A function together to activate GLUT4 transcription. Data obtained from transiently transfected cells support this hypothesis. Neither GEF nor MEF2A alone significantly activated GLUT4 promoter activity, but increased promoter activity 4- to 5-fold when expressed together. Deletion of the GEF-binding domain (domain I) and the MEF2-binding domain prevented activation, strengthening the conclusion that promoter regulation occurs through these elements. GEF and MEF2A, isolated from nuclei of transfected cells, bound domain I and the MEF2 domain, respectively, which is consistent with activation through these regulatory elements. Finally, GEF and MEF2A coimmunoprecipitated in vivo, strongly supporting a mechanism of GLUT4 transcription activation that depends on this protein-protein interaction.
Kondo M, Sawada K, Matsuda Y, Abe M, Sanechika N, Takanashi Y Biomedicines. 2024; 12(8).
PMID: 39200235 PMC: 11351524. DOI: 10.3390/biomedicines12081771.
RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer.
Prokakis E, Jansari S, Boshnakovska A, Wiese M, Kusch K, Kramm C Cell Death Dis. 2023; 14(9):641.
PMID: 37770435 PMC: 10539310. DOI: 10.1038/s41419-023-06157-5.
Wang R, Cheng X, Chi D, Liu S, Li Q, Chen B Discov Oncol. 2023; 14(1):99.
PMID: 37314494 PMC: 10267068. DOI: 10.1007/s12672-023-00710-6.
Niknafs S, Fortes M, Cho S, Black J, Roura E BMC Genomics. 2022; 23(1):393.
PMID: 35606689 PMC: 9128104. DOI: 10.1186/s12864-022-08625-2.
MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.
Liu B, Pang L, Ji Y, Fang L, Tian C, Chen J Front Cardiovasc Med. 2022; 8:775392.
PMID: 35047575 PMC: 8762055. DOI: 10.3389/fcvm.2021.775392.